Both in Biotechnology
Cardiff Oncology vs Kalaris Therapeutics
Over the past year CRDF returned −62.9% and KLRS returned −57.5%; their daily moves had a correlation of 0.14.
CRDF −62.9% KLRS −57.5%Growth of $1, one year, split-adjusted
| Metric | CRDF | KLRS |
|---|---|---|
| Price | $0.8579 | $2.12 |
| Market cap | $66.7M | $50.5M |
| Today | +1.61% | +6.00% |
| 1 month | −24.7% | −25.1% |
| 6 months | −46.7% | −60.0% |
| Year to date | −69.5% | −74.9% |
| 1 year | −63.5% | −57.9% |
| Revenue growth (YoY) | −14.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −8882.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 131.4× | — |
| Net cash | $34.5M | $93.5M |
| Dividend yield | — | — |
| Volatility (60d) | 71.6% | 57.4% |
| Short % of float | 17.7% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).